Literature DB >> 29764867

Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program.

Yuying Liu1,2, Jiadi Lv1, Xiaoyu Liang1, Xiaonan Yin1, Le Zhang1, Degao Chen1, Xun Jin1, Roland Fiskesund1, Ke Tang3, Jingwei Ma3, Huafeng Zhang3, Wenqian Dong1, Siqi Mo1, Tianzhen Zhang1, Feiran Cheng1, Yabo Zhou1, Jing Xie1, Ning Wang4,5, Bo Huang6,2,3.   

Abstract

Dormancy is recognized as a critical biological event for tumorigenic cells surviving in an extremely harsh environment. Understanding the molecular process of dormancy can unlock novel approaches to tackle cancers. We recently reported that stem-like tumor-repopulating cells (TRC) sense mechanical signals and rapidly proliferate in a 90 Pa soft fibrin matrix. Here, we show that a stiff mechanical environment induces TRC dormancy via an epigenetic program initiated by translocation of Cdc42, a cytosolic regulator of mechanotransduction, into the nucleus, where it promotes transcription of hydroxymethylating enzyme Tet2. Tet2 epigenetically activated cell-cycle-inhibiting genes p21 and p27 to induce dormancy, but also caused downregulation of integrin β3 to maintain dormancy. This stiffness-mediated dormancy was recapitulated in mouse models for both murine and primary human melanoma TRCs. These data identify an epigenetic program directed by mechanics, which drives highly tumorigenic TRCs to enter dormancy in a stiff mechanical environment.Significance: A mechanics-directed epigenetic program enables tumor-repopulating cells to enter dormancy in a stiff mechanical environment. Cancer Res; 78(14); 3926-37. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29764867     DOI: 10.1158/0008-5472.CAN-17-3719

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Matrix stiffness epigenetically regulates the oncogenic activation of the Yes-associated protein in gastric cancer.

Authors:  Minjeong Jang; Jinhyeon An; Seung Won Oh; Joo Yeon Lim; Joon Kim; Jung Kyoon Choi; Jae-Ho Cheong; Pilnam Kim
Journal:  Nat Biomed Eng       Date:  2020-12-07       Impact factor: 25.671

Review 2.  Forces in stem cells and cancer stem cells.

Authors:  Farhan Chowdhury; Bo Huang; Ning Wang
Journal:  Cells Dev       Date:  2022-03-26

Review 3.  Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge.

Authors:  Grace G Bushnell; Abhijeet P Deshmukh; Petra den Hollander; Ming Luo; Rama Soundararajan; Dongya Jia; Herbert Levine; Sendurai A Mani; Max S Wicha
Journal:  NPJ Breast Cancer       Date:  2021-05-28

Review 4.  The role of redox system in metastasis formation.

Authors:  Chiara Cencioni; Valentina Comunanza; Emanuele Middonti; Edoardo Vallariello; Federico Bussolino
Journal:  Angiogenesis       Date:  2021-04-28       Impact factor: 10.658

Review 5.  Integrated cancer tissue engineering models for precision medicine.

Authors:  Michael E Bregenzer; Eric N Horst; Pooja Mehta; Caymen M Novak; Shreya Raghavan; Catherine S Snyder; Geeta Mehta
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

6.  Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.

Authors:  Qiong Jia; Fang Yang; Wei Huang; Yao Zhang; Binghao Bao; Ke Li; Fuxiang Wei; Cunyu Zhang; Haibo Jia
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

7.  Compressive Stimulation Enhances Ovarian Cancer Proliferation, Invasion, Chemoresistance, and Mechanotransduction via CDC42 in a 3D Bioreactor.

Authors:  Caymen M Novak; Eric N Horst; Emily Lin; Geeta Mehta
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

Review 8.  MicroRNAs' control of cancer cell dormancy.

Authors:  Tatiana G Ruksha
Journal:  Cell Div       Date:  2019-10-10       Impact factor: 5.130

Review 9.  Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.

Authors:  Antonella Sistigu; Martina Musella; Claudia Galassi; Ilio Vitale; Ruggero De Maria
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

Review 10.  The updated landscape of tumor microenvironment and drug repurposing.

Authors:  Ming-Zhu Jin; Wei-Lin Jin
Journal:  Signal Transduct Target Ther       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.